Mesoblast
MESO
#4383
Rank
S$3.08 B
Marketcap
S$23.92
Share price
-2.76%
Change (1 day)
59.27%
Change (1 year)

Mesoblast (MESO) - Cash on Hand

Cash on Hand as of June 2025 : S$0.20 Billion

According to Mesoblast 's latest financial reports the company has S$0.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mesoblast - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30S$84.75 M-11.62%
2023-06-30S$95.89 M14.9%
2022-06-30S$83.45 M-54.51%
2021-06-30S$0.18 B2.11%
2020-06-30S$0.17 B165.79%
2019-06-30S$67.59 M33.25%
2018-06-30S$50.72 M377.21%
2017-06-30S$10.63 M-63.9%
2016-06-30S$29.44 M3.45%
2015-06-30S$28.46 M496.61%
2014-06-30S$4.77 M-52.26%
2013-06-30S$9.99 M468.22%
2012-06-30S$1.75 M-99.46%
2011-06-30S$0.32 B625.86%
2010-06-30S$44.5 M86.42%
2009-06-30S$23.87 M24.46%
2008-06-30S$19.18 M3.73%
2007-06-30S$18.49 M47.91%
2006-06-30S$12.5 M-51.08%
2005-06-30S$25.55 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
S$2.86 M-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S$0.17 M-99.92% Bahamas